| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65219-512-50 | 65219-512 | HUMAN PRESCRIPTION DRUG | Potassium Acetate | POTASSIUM ACETATE | INJECTION, SOLUTION, CONCENTRATE | INTRAVENOUS | 20241127 | N/A | ANDA | ANDA217515 | Fresenius Kabi USA, LLC | POTASSIUM ACETATE | 196 mg/mL | 25 VIAL, PHARMACY BULK PACKAGE in 1 TRAY (65219-512-50) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE (65219-512-02) |
| 65219-510-20 | 65219-510 | HUMAN PRESCRIPTION DRUG | Potassium Acetate | POTASSIUM ACETATE | INJECTION, SOLUTION, CONCENTRATE | INTRAVENOUS | 20241127 | N/A | ANDA | ANDA217515 | Fresenius Kabi USA, LLC | POTASSIUM ACETATE | 3.93 g/20mL | 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-510-20) / 20 mL in 1 VIAL, SINGLE-DOSE (65219-510-02) |